Explore
Validate
LearnABIN319332
antibody from antibodies-online
Targeting: FGFR1
BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN319332 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Fibroblast Growth Factor Receptor 1 (FGFR1) (AA 152-156) antibody
- Antibody type
- Polyclonal
- Description
- Immunoaffinity Chromatography using epitope-specific peptide
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- AA 152-156
- Vial size
- 50 μL
- Storage
- Store the antibody (in aliquots) at-20°C.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Heterodimerization of FGF-receptor 1 and PDGF-receptor-alpha: a novel mechanism underlying the inhibitory effect of PDGF-BB on FGF-2 in human cells.
Expression of basic fibroblast growth factor (bFGF), FGF receptor 1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle, after menopause and GnRHa treatment.
Isolation of axolemma-enriched fractions from bovine central nervous system.
Faraone D, Aguzzi MS, Ragone G, Russo K, Capogrossi MC, Facchiano A
Blood 2006 Mar 1;107(5):1896-902
Blood 2006 Mar 1;107(5):1896-902
Expression of basic fibroblast growth factor (bFGF), FGF receptor 1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle, after menopause and GnRHa treatment.
Wu X, Blanck A, Olovsson M, Möller B, Lindblom B
Acta obstetricia et gynecologica Scandinavica 2001 Jun;80(6):497-504
Acta obstetricia et gynecologica Scandinavica 2001 Jun;80(6):497-504
Isolation of axolemma-enriched fractions from bovine central nervous system.
De Vries GH
Neuroscience letters 1976 Oct;3(3):117-22
Neuroscience letters 1976 Oct;3(3):117-22
No comments: Submit comment
No validations: Submit validation data